Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP421644.RAE-Zz7EgJMhxpu3HH_2p66_9cZ-A3bV8jLQzO6Y3Ci_g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP421644.RAE-Zz7EgJMhxpu3HH_2p66_9cZ-A3bV8jLQzO6Y3Ci_g130_assertion type Assertion NP421644.RAE-Zz7EgJMhxpu3HH_2p66_9cZ-A3bV8jLQzO6Y3Ci_g130_head.
- NP421644.RAE-Zz7EgJMhxpu3HH_2p66_9cZ-A3bV8jLQzO6Y3Ci_g130_assertion description "[ZNF342 expression is specifically decreased in primary oligodendrogliomas and up-regulated in glioma cell lines treated with a demethylating agent, whereas the expression level of the adjacent gene, Gemin7, is not consistently altered in these samples.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP421644.RAE-Zz7EgJMhxpu3HH_2p66_9cZ-A3bV8jLQzO6Y3Ci_g130_provenance.
- NP421644.RAE-Zz7EgJMhxpu3HH_2p66_9cZ-A3bV8jLQzO6Y3Ci_g130_assertion evidence source_evidence_literature NP421644.RAE-Zz7EgJMhxpu3HH_2p66_9cZ-A3bV8jLQzO6Y3Ci_g130_provenance.
- NP421644.RAE-Zz7EgJMhxpu3HH_2p66_9cZ-A3bV8jLQzO6Y3Ci_g130_assertion SIO_000772 14633674 NP421644.RAE-Zz7EgJMhxpu3HH_2p66_9cZ-A3bV8jLQzO6Y3Ci_g130_provenance.
- NP421644.RAE-Zz7EgJMhxpu3HH_2p66_9cZ-A3bV8jLQzO6Y3Ci_g130_assertion wasDerivedFrom befree-2016 NP421644.RAE-Zz7EgJMhxpu3HH_2p66_9cZ-A3bV8jLQzO6Y3Ci_g130_provenance.
- NP421644.RAE-Zz7EgJMhxpu3HH_2p66_9cZ-A3bV8jLQzO6Y3Ci_g130_assertion wasGeneratedBy ECO_0000203 NP421644.RAE-Zz7EgJMhxpu3HH_2p66_9cZ-A3bV8jLQzO6Y3Ci_g130_provenance.